MEB
Medibio
- Short interest
- 0.00%
- −0.10 pp 30d
- as of 23 July 2020
- Reported shorts
- 66.8K
- Shares on issue
- 1.348B
Medibio (MEB) financials
Results, ratios and statements
Fundamentals
Our data providers hold no financial statements for MEB (last checked 15 Oct 2026). The company's own filings are listed below.
Financial reports
The company's own filings, newest first
- March 2026 Quarterly Activities Report and Appendix 4CQuarterly Report30 Apr 2026via asx_announcements
- Appendix 4D & Half-Year Financial Report to 31 December 2025Half Year Results24 Feb 2026via asx_announcements
- December 2025 Quarterly Activities Report and Appendix 4CQuarterly Report30 Jan 2026via asx_announcements
- September 2025 Quarterly Activities Report and Appendix 4CQuarterly Report31 Oct 2025via asx_announcements
- 2025 Annual ReportAnnual Report29 Sep 2025via asx_announcements
- Appendix 4E - Preliminary Final ReportAnnual Results29 Aug 2025via asx_announcements
- June 2025 Quarterly Activities Report and Appendix 4CQuarterly Report31 Jul 2025via asx_announcements
- March 2025 Quarterly Activities Report and Appendix 4CQuarterly Report30 Apr 2025via asx_announcements
- Appendix 4D & Half-Year Financial Report to 31 December 2024Half Year Results28 Feb 2025via asx_announcements
- December 2024 Quarterly Activities Report and Appendix 4CQuarterly Report31 Jan 2025via asx_announcements
Showing 10 of 83 reports